TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/15/25 16:33 | 8/13/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 10 | 28 | S.dm | -22,898 | 86.97 | 0 | -263 | 1,142 | D | |||||||||||||||
8/15/25 16:07 | 8/13/25 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 7 | 12 | S.d | -12,111 | 34.18 | 0 | -354 | 110 | D | |||||||||||||||
8/14/25 18:01 | 8/12/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 9 | 11 | S.d | -39,736 | 598.78 | 0 | -66 | 149 | D | |||||||||||||||
7/25/25 16:05 | 7/23/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 11 | 18 | S.dm | -1,119 | 12.43 | 0 | -90 | 1,657 | D | |||||||||||||||
7/1/25 16:59 | 6/27/25 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 1 | 1 | S | -41 | 5.06 | 0 | -8 | 12 | D | |||||||||||||||
2/3/25 19:26 | 1/31/25 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 1 | 3 | S.ad | -447 | 35.64 | 0 | -13 | 111 | D | |||||||||||||||
10/11/24 17:23 | 9/11/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 8 | 10 | S.m | -8,940 | 25.63 | 0 | -349 | 1,595 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |